ANV700 is a novel proximity-activated IL-21 receptor agonist designed to selectively reinvigorate tumor-reactive PD-1 expressing T cells

ANV-700 - Anaveon

https://dx.doi.org/10.1136/jitc-2024-SITC2024.0960

Alexander Rau; Nicole Egli; Patrizia Murer; Laetitia Petersen; Christian Stocker; Kirsten Richter; Christoph Huber

Oct 4, 2024